DK1479394T3 - Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr - Google Patents

Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr

Info

Publication number
DK1479394T3
DK1479394T3 DK04019831T DK04019831T DK1479394T3 DK 1479394 T3 DK1479394 T3 DK 1479394T3 DK 04019831 T DK04019831 T DK 04019831T DK 04019831 T DK04019831 T DK 04019831T DK 1479394 T3 DK1479394 T3 DK 1479394T3
Authority
DK
Denmark
Prior art keywords
egf
animal
growth factor
increase
epidermal growth
Prior art date
Application number
DK04019831T
Other languages
Danish (da)
English (en)
Inventor
Andre G Buret
D Grant Gall
James A Hardin
Merle E Olson
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Application granted granted Critical
Publication of DK1479394T3 publication Critical patent/DK1479394T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK04019831T 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr DK1479394T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent
PCT/CA1996/000291 WO1996035445A1 (en) 1995-05-10 1996-05-09 The use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (1)

Publication Number Publication Date
DK1479394T3 true DK1479394T3 (da) 2007-06-11

Family

ID=23742496

Family Applications (3)

Application Number Title Priority Date Filing Date
DK04019831T DK1479394T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr
DK00123426T DK1092437T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DK96913397T DK0824357T3 (da) 1995-05-10 1996-05-09 Anvendelsen af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK00123426T DK1092437T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DK96913397T DK0824357T3 (da) 1995-05-10 1996-05-09 Anvendelsen af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel

Country Status (13)

Country Link
US (2) US5753622A (de)
EP (3) EP1479394B1 (de)
JP (1) JP3549541B2 (de)
AT (3) ATE357927T1 (de)
AU (1) AU704675B2 (de)
CA (2) CA2220434C (de)
DE (3) DE69637002T2 (de)
DK (3) DK1479394T3 (de)
ES (2) ES2226681T3 (de)
HK (1) HK1072894A1 (de)
NZ (2) NZ501482A (de)
PT (1) PT1479394E (de)
WO (1) WO1996035445A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
CN1527879A (zh) * 2001-05-18 2004-09-08 加拿大农业及农业食品部 牛表皮生长因子的核酸序列和蛋白质序列
WO2003035102A1 (en) * 2001-10-26 2003-05-01 University Technologies International, Inc. Use of egf to inhibit pathogenic infections of the urogenital tract
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
AU2003250250B2 (en) 2002-06-19 2008-02-14 Intrexon Actobiotics Nv Methods and means to promote gut absorption
US20110245171A1 (en) * 2004-09-30 2011-10-06 Hardin James A Rehydration compositions comprising epidermal growth factor (egf)
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
US20110275566A1 (en) * 2008-10-10 2011-11-10 Nationwide Children's Hospital Inc. Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
ATE80307T1 (de) * 1986-12-11 1992-09-15 British Tech Group Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.
EP0577903B1 (de) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Lactobacillus Acidophilus enthaltende Antigastritis-Mittel
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
HK1072894A1 (en) 2005-09-16
DE69637002D1 (de) 2007-05-10
ATE357927T1 (de) 2007-04-15
US6656907B1 (en) 2003-12-02
JPH11505528A (ja) 1999-05-21
DK0824357T3 (da) 2001-10-08
DE69614377D1 (de) 2001-09-13
EP1479394B1 (de) 2007-03-28
ATE203912T1 (de) 2001-08-15
DE69614377T2 (de) 2002-05-23
EP1092437B1 (de) 2004-10-06
CA2492724C (en) 2010-08-03
EP0824357B1 (de) 2001-08-08
ES2226681T3 (es) 2005-04-01
AU5641196A (en) 1996-11-29
DE69633583D1 (de) 2004-11-11
ATE278415T1 (de) 2004-10-15
EP0824357A1 (de) 1998-02-25
AU704675B2 (en) 1999-04-29
EP1479394A1 (de) 2004-11-24
JP3549541B2 (ja) 2004-08-04
DK1092437T3 (da) 2005-01-31
DE69637002T2 (de) 2007-08-16
CA2220434C (en) 2005-02-22
WO1996035445A1 (en) 1996-11-14
DE69633583T2 (de) 2006-02-23
CA2220434A1 (en) 1996-11-14
US5753622A (en) 1998-05-19
NZ307134A (en) 2000-02-28
EP1092437A1 (de) 2001-04-18
ES2285320T3 (es) 2007-11-16
NZ501482A (en) 2004-12-24
PT1479394E (pt) 2007-04-30
CA2492724A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
HK1072894A1 (en) The use of epidermal growth factor (egf) for increasing weight gain in an animal
ES2130173T3 (es) Xilanasa, secuencia correspondiente de adn recombinante, agente que contiene la xilanasa, y uso del agente.
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
MD1632F2 (en) Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
DE69131589T2 (de) Ribosomen-inaktivierende Proteine, inaktive Vorläuferformen derselben, Verfahren zur Herstellung und eine Methode zur Nutzung
DE3586346D1 (de) Mikrobielle herstellung von propionsaeure in mischkultur.
DE59712094D1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ATE30729T1 (de) Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren.
ATE47274T1 (de) Tierstreu sowie verfahren zur herstellung derselben.
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE59006307D1 (de) Badezusatz und dessen Verwendung.
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
DE68914660D1 (de) Verfahren zur Herstellung von den Safranblütennarben ähnlichem Gewebe sowie Verfahren zur Herstellung von nützlichen Stoffen aus safranblütennarbenähnlichem Gewebe.
JPS5729270A (en) Preparation of nonheat-coagulable egg white
ATE84295T1 (de) Verfahren zur herstellung von 2,6,6-trimethylcyclohex-2-en-1,4-dion.
AU2719488A (en) Method for supplying an oblong plant trough with end walls and apparatus for carrying out the method
BG60542B2 (en) Water soluble composition having coccidiostatic effect
ATE84194T1 (de) Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
MD512C2 (ro) Inhibitor dezvoltării mugurilor la altoaiele viţei de vie
CA2031825A1 (en) Bath additive and its use